drugset / Trial / NCT04281862

DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery

NCT04281862 ↗

Phase 4 Unknown 20 enrolled Vance Thompson Vision
RandomizedCrossoverOpen-labelTreatment

Summary

To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen in the contralateral eye following bilateral LASIK surgery.

Timeline

Start
2020-01-23
Primary completion
2020-04-01
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Comparator Prednisolone Other / unclassified 1 % Topical

Indications

No indication recorded.